JAMA Ophthalmology
Tracked across 1 events · 7 articles · First seen May 22, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: JAMA Ophthalmology is a medical journal that published a 2025 study examining patients who developed optic nerve disorders after using GLP-1 medications, providing scientific evidence relevant to the lawsuits.
May 22, 2026 · 7 articles
ERGEN INTELLIGENCE
Track JAMA Ophthalmology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard